Ruthenium Complexes as Promising Candidates against Lung Cancer.
Ruthenium Complexes as Promising Candidates against Lung Cancer.
复制标题
钌配合物作为抗肺癌的有希望的候选者
DOI:
10.3390/molecules26154389
复制
发表时间:
2021-07-21
期刊:
影响因子:
--
通讯作者:
Zhang Q
中科院分区:
文献类型:
--
作者:
Sun Q;Li Y;Shi H;Wang Y;Zhang J;Zhang Q
Lung cancer is one of the most common malignancies with the highest mortality rate and the second-highest incidence rate after breast cancer, posing a serious threat to human health. The accidental discovery of the antitumor properties of cisplatin in the early 1960s aroused a growing interest in metal-based compounds for cancer treatment. However, the clinical application of cisplatin is limited by serious side effects and drug resistance. Therefore, other transition metal complexes have been developed for the treatment of different malignant cancers. Among them, Ru(II/III)-based complexes have emerged as promising anticancer drug candidates due to their potential anticancer properties and selective cytotoxic activity. In this review, we summarized the latest developments of Ru(II/III) complexes against lung cancer, focusing mainly on the mechanisms of their biological activities, including induction of apoptosis, necroptosis, autophagy, cell cycle arrest, inhibition of cell proliferation, and invasion and metastasis of lung cancer cells.
登录
查看更多内容
影响因子:
--
作者:
Chen L;Li G;Peng F;Jie X;Dongye G;Cai K;Feng R;Li B;Zeng Q;Lun K;Chen J;Xu B
通讯作者:
Xu B
影响因子:
4.6
作者:
Costa MS;Gonçalves YG;Borges BC;Silva MJB;Amstalden MK;Costa TR;Antunes LMG;Rodrigues RS;Rodrigues VM;de Faria Franca E;Zoia MAP;de Araújo TG;Goulart LR;Von Poelhsitz G;Yoneyama KAG
通讯作者:
Yoneyama KAG
影响因子:
5.7
作者:
Bade, Brett C.;Dela Cruz, Charles S.
通讯作者:
Dela Cruz, Charles S.
影响因子:
3.9
作者:
Chen, Lan-mei;Peng, Fa;Chen, Jin-can
通讯作者:
Chen, Jin-can
影响因子:
1.2
作者:
Biancalana, Lorenzo;Pampaloni, Guido;Marchetti, Fabio
通讯作者:
Marchetti, Fabio